Illumina, Inc.

Illumina, Inc.

Illumina, Inc.

Overview
Date Founded

2000

Headquarters

5200 ILLUMINA WAY, SAN DIEGO, CA, 92122

Type of Company

Public

Employees (Worldwide)

7,300

Industries

Industrial Machinery & Manufacturing
Computer Software
Medical Support Services
Biotechnology

Company Description

Illumina, Inc. engages in the development and manufacture of integrated systems for the analysis of genetic variation and function. It operates through the Core Illumina and Consolidated Variable Interest Entity segments (VIE). The Core Illumina segments serve customers in the research, clinical and applied markets, and enable the adoption of genomic solutions. The Consolidated VIE segment includes activities of GRAIL and Helix. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Contact Data
Trying to get in touch with decision makers at Illumina, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President & Chief Executive Officer

Senior Vice President & Chief Financial Officer

Senior Vice President, General Counsel & Secretary

Senior Vice President & Chief Technology Officer

Senior Vice President & Chief Commercial Officer

Vice President & Chief Accounting Officer

Senior Vice President & Chief People Officer

Chief Medical Officer

Vice President & General Manager-Asia Pacific & Japan

Senior Vice President & General Manager, Commercial Operations-Europe, Middle East & Africa

Board of Directors

Former President & Chief Executive Officer at Illumina, Inc.

President & Chief Executive Officer at Illumina, Inc.

Co-Founder at Provivi, Inc.

President, Chief Executive Officer & Director at Intuitive Surgical, Inc.

Venture Partner at Lightspeed Management Co. LLC

Chief Executive Officer at GE Ventures LLC

Fund Advisor at Goldman Sachs Asset Management LP

Senior Vice President Worldwide Marketing at Apple, Inc.

Advisor at Medocity, Inc.

Paths to Illumina, Inc.
Potential Connections via
Relationship Science
You
Illumina, Inc.
Owners & Shareholders
Details Hidden

Baillie Gifford is an active, team-oriented, research-based manager which is completely focused on delivering long-term returns. The firm's investment philosophy focuses on growth while their universe is global. They employ bottom-up conviction to portfolio construction. Their diversified strategies maximize investment opportunities, aiming to achieve steady returns. For equities, Baillie Gifford's analysts conduct qualitative, fundamental analysis to identify the most competitive, innovative and efficient growth companies. For multi-asset strategy, the firm invests in various asset classes such as listed equities, property, high yield credit, commodities, emerging market government bonds and insurance linked securities. For fixed-income, Baillie Gifford invests in government bonds and currencies, emerging market bonds, investment grade and high yield.

Details Hidden

Capital World Global Investors (CWGI) is the investment adviser to the American Funds Group, a family of 30 funds marketed to individuals exclusively through financial advisers and other intermediaries. American Funds are also used as investment vehicles for 401ks, other retirement plans, variable annuities and 529 college savings plans. The funds have the following characteristics: (1) a long-term, value-oriented approach (2) long-established, global research (3) a multiple portfolio counselor system that combines teamwork with individual accountability (4) experienced, long-tenured investment professionals and (5) a commitment to low operating expenses, among the lowest in the fund industry. CWGI uses a Multiple Portfolio Counselor System. The assets of each fund are divided into smaller, more manageable portions. Each portion is managed by a portfolio counselor who operates autonomously, investing his or her portion as though it were an entire fund (subject to fund objectives and overall guidelines). Research analysts typically manage a segment as well, bringing their expertise directly to bear on the fund's results. Portfolio counselors are free to make their own decisions. As a fund's assets grow, new counselors can be added. Investment decisions are based on internal research. Equity research is comprehensive and bottom-up while at the same time constantly monitoring broader economic, political, currency and interest rate trends. Investment research is proprietary and used solely by CWGI portfolio managers.

Details Hidden

Jennison Associates has expertise in a range of equity strategies across styles and market-caps, as well as fixed income strategies. The firm manages portfolios based on internal fundamental research, bottom-up security selection and a highly interactive investment process. Jennison Associates specializes in fundamental analysis, which involves attempting to gain insight into the future value of a company by studying company-specific and market-related quantitative (such as financial statements) and qualitative (such as quality of company management or products) information. Although portfolio managers ultimately make investment decisions for the portfolios they manage, they work closely with research analysts and other portfolio managers in a dynamic and continuous process of updating and debating investment ideas and company-specific convictions. They use quantitative tools to create and manage some of their customized equity portfolios and their quantitatively hedged portfolios.

Recent Transactions
Details Hidden

Illumina, Inc. purchases Pacific Biosciences of California, Inc.

Details Hidden

Illumina, Inc. purchases Edico Genome Corp. from Qualcomm Ventures, Dell Technologies Capital

Details Hidden

Illumina, Inc. purchases GenoLogics Life Sciences Software, Inc. from OVP Venture Partners, GrowthWorks Capital Ltd., Yaletown Venture Partners, Inc.

Insider Transactions
Details Hidden
Details Hidden
Details Hidden
Transaction Advisors
Underwriter

Advised onIllumina, Inc. issued Common Stock

Legal Advisor

Advised onIllumina, Inc. purchases Pacific Biosciences of California, Inc.

Underwriter

Advised onIllumina, Inc. issued Common Stock

Legal Advisor

Advised onIllumina, Inc. purchases Pacific Biosciences of California, Inc.

Legal Advisor

Advised onIllumina, Inc. purchases Pacific Biosciences of California, Inc.

Investment Advisor

Advised onIllumina, Inc. purchases Verinata Health, Inc.

Advisors & Consultants
Legal Advisor

Founding Partner at Wilson Sonsini Goodrich & Rosati PC

Legal Advisor

Partner at Wilson Sonsini Goodrich & Rosati PC

Legal Advisor

Partner at Weil, Gotshal & Manges LLP

Clients

Government of the United Kingdom is the central government of the United Kingdom of Great Britain and Northern Ireland.The government is led by the Prime Minister, who selects all the remaining ministers. The prime minister and the other most senior ministers belong to the supreme decision-making committee, known as the Cabinet.

Natera, Inc. engages in the discovery, development, and commercialization of genetic testing services. It offers Panorama Non-Invasive Prenatal Test, Horizon Carrier Screening, Spectrum Pre-implantation Genetic Screening and Spectrum Pre-implantation Genetic Diagnosis, Anora Products of Conception and Non-Invasive Paternity Testing. The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in San Carlos, CA.

Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. It harnesses the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson in September 2009 and is headquartered in Seattle, WA.

Key Stats and Financials As of 2018
Market Capitalization
$43.2B
Total Enterprise Value
$43.1B
Earnings Per Share
$5.54
Revenue
$3.33B
Total Debt
$2B
Total Equity
$3.91B
Net Profit
$826M
Five Year Compounded Annual Growth Rate Of Revenue
18.59%
Three Year Compounded Annual Growth Rate Of Revenue
14.51%
Enterprise Value Sales
12.92x
TEVNet Income
52.14x
Debt TEV
0.05x
EBITDA
$1.06B
EBITDAMargin
31.86%
Enterprise Value EBITDAOperating
40.55x
Non-Profit Donations & Grants
$5,000 +
2017
$1 - $10K
2013
$10K - $25K
2008
Investments
Details Hidden

Desktop Genetics Ltd. develops software tools to enable literal desktop genetics. It offers technologies at the intersection of biotechnology, software and laboratory automation. The firm's DESKGEN platform, an intuitive and powerful system that supports the optimal design, construction, management, and purchase of the DNA, reagents and services important in gene editing and molecular biology. The company was founded by Victor Dillard, Riley Doyle and Edward Perello in 2012 and is headquartered in London, the United Kingdom.

Details Hidden

Trace Genomics, Inc. develops soil testing kit and pathogen panel that enables detection of pathogens and beneficial organisms. Its products include disease discovery, pathogen panel and soil health. The company was founded by Poornima Parameswaran and Diane Wu and is headquartered in Burlingame, CA.

Details Hidden

Human Longevity, Inc. provides genomics and cell therapy-based diagnostic and therapeutic services. It is developing and applying large scale computing and machine learning to make novel discoveries to revolutionize the practice of medicine. The company was founded by J. Craig Venter, Robert Joseph Hariri Gordon, and Peter H. Diamandis in 2013 and is headquartered in San Diego, CA.

Investors
Details Hidden

Executive Chairman at Kaazing Corp.

Details Hidden

Founder at Pharmacopeia LLC

Details Hidden

Chief Executive Officer & Chief Scientific Officer at Prognosys Biosciences, Inc.

Suppliers
Alexandria Real Estate Equities, Inc. Trusts & Funds | Pasadena, CA

Alexandria Real Estate Equities, Inc. is an urban office real estate investment trust, which engages in the ownership, operation, development, and redevelopment of life science and technology properties. It also provides a space for lease to the life science and technology industries which are primarily located in AAA urban innovation cluster locations. The company was founded by Alan D. Gold, Gary A. Kreitzer, Joel S. Marcus, and Jerry M. Sudarsky in October 1994 and is headquartered in Pasadena, CA.

AIMS APAC REIT Management Ltd. Real Estate Investment Trusts | Singapore, CE

AIMS APAC REIT Management Ltd. operates as a real estate investment trust. It invests in a portfolio of income-producing real estate located throughout the Asia-Pacific region that is used for industrial purposes, including, but not limited to, warehousing and distribution activities, business park activities, and manufacturing activities. The company was founded on December 5, 2006 and is headquartered in Singapore.

Sequenom Inc. Biotechnology | SAN DIEGO, CA

Sequenom, Inc. engages in the provision of early patient management information. It develops and commercializes molecular diagnostic testing services that serve women's health and oncology markets. The company was founded by Hubert Koester and Charles R. Cantor in October 09, 1996 and is headquartered in San Diego, CA.

Competitors
Thermo Fisher Scientific, Inc. Industrial Machinery & Manufacturing - Waltham, Massachusetts

Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions; Analytical Instruments; Specialty Diagnostics; and Laboratory Products and Services. The Life Sciences Solutions segment comprises of portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs, and vaccines as well as diagnosis of disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment gives diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment involves in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.

Agilent Technologies, Inc. Industrial Machinery & Manufacturing - Santa Clara, CA

Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that enable to identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. The Diagnostics and Genomics segment comprises activity providing active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software, and consumables. The Agilent CrossLab segment includes startup, operational, training and compliance support, software as a service, and asset management and consultative services. The company was founded in May 1999 and is headquartered in Santa Clara, CA.

Roche Holding AG Pharmaceuticals - Basel, BS

Roche Holding ag Roche Personalised Healthcare – our mission The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models. Growing demand for highly effective, impactful medicines is being driven by an aging population, healthcare and economic pressures. But an influx of new technologies enables Roche to meet this need by offering innovative tests and medicines. These healthcare drivers have led us in one direction – ‘Roche Personalised Healthcare’. At Roche, ‘Personalised Healthcare’ is at the core of our business strategy

Awards & Honors
Rank #912
2016
Fortune Magazine - Fortune 1000 Companies
Sponsored by Fortune Magazine
Rank #36
2014
Forbes - World's 100 Most Innovative Companies
Sponsored by Forbes Magazine
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Illumina, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Illumina, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Illumina, Inc..
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/organization/illumina-inc-51368
  • https://relationshipscience.com/organization/illumina-inc-51368